Request a representative visit or G7 15 Day or G7 samples
CSS HERE, do not delete
The Dexcom Portfolio:
Delivers improved glycemic outcomes in diabetes1-5
Check out Dexcom G7 15 Day, the latest win in our portfolio.
Glucose management devices tailored to your patients’ needs*
Prescribe G7 15 Day for adult patients 18+ with:
- Type 1 or type 2 diabetes, regardless of insulin use6
- Diabetes during pregnancy
- AID (automated insulin delivery) system
- Most-covered CGM brand for all types of diabetes†,7
- Available at pharmacies and DME suppliers
Prescribe G7 for pediatric patients aged 2+ or adult patients with:
- Type 1 or type 2 diabetes whether they use insulin or not8
- AID (automated insulin delivery) system
- Most-covered CGM brand for all types of diabetes†,7
- Available at pharmacies and DME suppliers
Recommend Stelo for adult patients aged 18+ with9:
- Prediabetes
- An interest in tracking their glucose for health insights
- Type 2 diabetes not on insulin who do not have insurance coverage for CGM
- No prescription needed
Noteworthy news
Stay informed with the latest updates on interoperability and coverage for Dexcom products.
CONNECT data
CONNECT is the first and only Level A evidence demonstrating strong benefit of CGM for patients with type 2 diabetes not using insulin. See the real-world data.10
Tandem connectivity
Dexcom G7 15 Day is now compatible with the Tandem Mobi system and the Tandem t:slim X2 insulin pump. Dexcom G7 15 Day can help deliver a smoother and more dependable AID experience for your patients to help enhance their overall glucose management.7
Coverage wins
Now even more of your patients have access to Dexcom G7 15 Day. Dexcom G7 15 Day is now covered by Anthem BCBS (Elevance Health) as of April 2026. Prime Therapeutics (BCBS) has also expanded their coverage to include Dexcom G7 15 Day, effective July 2026.†,‡,7
Explore Dexcom resources, educational materials, and connected partners.
AID=automated insulin delivery; CGM=continuous glucose monitoring; DME=durable medical equipment.
*Compared to previous app experience. †Individual coverage may vary depending on insurance plan.
References: 1. Beck RW, et al. JAMA. 2017;317(4):371-378. 2. Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 3. Martens T, et al. JAMA. 2021;325(22):2262-2272. 4. Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 5. Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-147. 6. Dexcom G7 15 Day User Guide 2025. 7. Data on file, Dexcom. 2025. 8. Dexcom G7 User Guide 2025. 9. Dexcom Stelo User Guide 2025. 10. Martens TW, et al. Cleve Clin J Med. 2024;91(10):611-620.
MAT-11231